CLRO is trading at $12.54 (79.1% up) as the market continues to react to the recently announced Cortigent merger.
- The stock has seen extreme volatility and a significant rally since the definitive merger agreement with Cortigent, a Vivani Medical subsidiary, was announced on July 2, 2026.
- No new specific company announcements appear to be driving today's continued upward momentum, beyond the ongoing market adjustment to the transformative merger.